Found 4 matching trials
QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms
PHASE2The purpose of the study is to compare the efficacy of QLS4131(SC) in combi...
Location
Multiple Locations
A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma
PHASE1The purpose of this study is to characterize the safety of QLS4131 injectio...
Location
Institute of Hematology & Blood Diseases Hospital
A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus
PHASE1The goal of this open label, dose escalation phase 1b clinical trial is to ...
Location
Multiple Locations
BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004)
PHASE2Systemic light-chain (AL) amyloidosis is a plasma cell disorder characteriz...
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences